wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35525569-08A3BC39-D439-42BC-AA81-49FAE6997E0D
Q35525569-08A3BC39-D439-42BC-AA81-49FAE6997E0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35525569-08A3BC39-D439-42BC-AA81-49FAE6997E0D
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas.
P2860
Q35525569-08A3BC39-D439-42BC-AA81-49FAE6997E0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35525569-08A3BC39-D439-42BC-AA81-49FAE6997E0D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e528fd74e459800a3d0ecb4657da7f9d83d780cb
P2860
The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation